Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cindy Wang

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 28, 2021
Targeting myosin 1c inhibits murine hepatic fibrogenesisEhtesham Arif, Cindy Wang, Marzena K Swiderska-Syn, et al.
Ejhaem|August 21, 2023
SARS-CoV-2 infections in patients enrolled on the Children's Oncology Group standard-risk B-cell acute lymphoblastic leukemia trial, AALL1731Caitlin W Elgarten, John A Kairalla, Joel C Thompson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2020
Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Oncology GroupSumit Gupta, Cindy Wang, Elizabeth A Raetz, et al.
Pediatric Blood & Cancer|June 1, 2023
Minimal residual disease predicts outcomes in KMT2A-rearranged but not KMT2A-germline infant acute lymphoblastic leukemia: Report from Children's Oncology Group study AALL0631Kelly E Faulk, John A Kairalla, ZoAnn E Dreyer, et al.
Genome Medicine|August 8, 2025
Building digital histology models of transcriptional tumor programs with generative deep learning for pathology-based precision medicineHanna M Hieromnimon, James Dolezal, Kristina Doytcheva, et al.
Kidney International|May 18, 2019
The motor protein Myo1c regulates transforming growth factor-β-signaling and fibrosis in podocytesEhtesham Arif, Ashish K Solanki, Pankaj Srivastava, et al.
Leukemia|February 24, 2021
FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631Patrick A Brown, John A Kairalla, Joanne M Hilden, et al.
Blood Advances|April 15, 2026
Chromosome 15q deletions confer inferior outcomes among children with ETV6::RUNX1 B-Cell Acute Lymphoblastic LeukemiaRuth W Wang'ondu, John A Kairalla, Mary Shago, et al.
Leukemia|April 13, 2021
Correction to: FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631Patrick A Brown, John A Kairalla, Joanne M Hilden, et al.
Pediatric Blood & Cancer|September 9, 2022
Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology GroupCaitlin W Elgarten, Joel C Thompson, Anne Angiolillo, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 28, 2021
Targeting myosin 1c inhibits murine hepatic fibrogenesisEhtesham Arif, Cindy Wang, Marzena K Swiderska-Syn, et al.
Ejhaem|August 21, 2023
SARS-CoV-2 infections in patients enrolled on the Children's Oncology Group standard-risk B-cell acute lymphoblastic leukemia trial, AALL1731Caitlin W Elgarten, John A Kairalla, Joel C Thompson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2020
Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Oncology GroupSumit Gupta, Cindy Wang, Elizabeth A Raetz, et al.
Pediatric Blood & Cancer|June 1, 2023
Minimal residual disease predicts outcomes in KMT2A-rearranged but not KMT2A-germline infant acute lymphoblastic leukemia: Report from Children's Oncology Group study AALL0631Kelly E Faulk, John A Kairalla, ZoAnn E Dreyer, et al.
Genome Medicine|August 8, 2025
Building digital histology models of transcriptional tumor programs with generative deep learning for pathology-based precision medicineHanna M Hieromnimon, James Dolezal, Kristina Doytcheva, et al.
Kidney International|May 18, 2019
The motor protein Myo1c regulates transforming growth factor-β-signaling and fibrosis in podocytesEhtesham Arif, Ashish K Solanki, Pankaj Srivastava, et al.
Leukemia|February 24, 2021
FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631Patrick A Brown, John A Kairalla, Joanne M Hilden, et al.
Blood Advances|April 15, 2026
Chromosome 15q deletions confer inferior outcomes among children with ETV6::RUNX1 B-Cell Acute Lymphoblastic LeukemiaRuth W Wang'ondu, John A Kairalla, Mary Shago, et al.
Leukemia|April 13, 2021
Correction to: FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631Patrick A Brown, John A Kairalla, Joanne M Hilden, et al.
Pediatric Blood & Cancer|September 9, 2022
Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology GroupCaitlin W Elgarten, Joel C Thompson, Anne Angiolillo, et al.
Pageof 9